Situasi Paten Obat Anti Diabetes, Anti Hipertensi, Anti Malaria Dan Anti Tuberkulosis Di Indonesia

Utami, Basundari Sri; Tuti, Sekar; Anggraini, Anggita Bunga; Faatih, Mukhlissul; Siswanto, Siswanto; Trihono, Trihono

doi:10.22435/mpk.v24i2.3568.103-110

Cited by 3 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The patent system could protect innovative inventions from developed countries. However, on the other hand, the patent system could not protect inventions in developing countries (Utami et al, 2014). The current study data cover these two types of patents and do not separate them.…”

Section: Introductionmentioning

confidence: 93%

The significance of standard, patent and labour on import value: case study in Indonesia

Tampubolon

2022

MMI

View full text Add to dashboard Cite

Being a never-ending debate, the direction of developing standards has to be in the opposite direction in facilitating international trade. This study investigated the relationship of standard, patent, and labor on Indonesian import. This study found some differences and very diverse correlations between the components in the second factor, both positively and negatively correlated. Those studies are generally carried out by developed countries, where the infrastructure to support innovation and standards has developed rapidly. The analysis of this research was carried out using panel data regression and the Cobb-Douglas function. Estimation was carried out using the fix effect and the random effect models. The robust model found variables that impact Indonesian import performance, both simultaneous and partial tests. In addition, a significant impact of the contribution of national standards on the growth of import value and sectors was determined. The low growth rate of patents for the same sector shows the innovation sectors that contributed less to the import value when observed more deeply. In contrast to national standards tending to be domestic, the growth standard of a sector will be inversely proportional to the growth in the value of imports in that sector, except for sectors whose conformity assessment does not support infrastructure. Besides, this study found that labor had no significant impact on import value. However, there was a significant potential from developing national standards and adopting international standards for the growth of national import performance in Indonesia. In addition to functioning as an empirical investigation of the effect of the growth of national standards, the adoption of international standards, labor, and patents on the growth of import value, it also looks at the contribution to the knowledge of developing countries' import growth factors, especially those related to standardization. The analysis shows that national standard growth and adoption growth differently contribute to Indonesian import performance. The findings show that the two factors in standard development have different functions in import performance. This paper further contributed to the knowledge of import growth factors of a developing country, particularly those related to standardization.

show abstract

Section: Introductionmentioning

confidence: 93%

The significance of standard, patent and labour on import value: case study in Indonesia

Tampubolon

2022

MMI

View full text Add to dashboard Cite

show abstract

“…Oleh karena itu, Indonesia memiliki kesempatan besar untuk mengembangkan potensi bahan alam yang dimiliki, baik berupa tanaman obat, agen penyakit untuk dikembangkan menjadi produk kesehatan inovatif yang dapat memenuhi kebutuhan kesehatan mandiri. (Utami et al, 2014), (Aryanto Heri, 2014) Informasi tentang hak kekayaan intelektual (paten) di Indonesia yang terkait dengan produk kesehatan (obat, kit diagnostik maupun alat kedokteran fungsional) masih belum banyak diketahui. Informasi dari Ditjen HKI, Kementerian Hukum dan HAM R.I. mengatakan meskipun jumlah pemohon hak paten yang dilakukan oleh para inventor Indonesia mengalami peningkatan, namun jumlah seluruhnya relatif rendah dibanding pemohon asing.…”

Section: Pendahuluanunclassified

“…Kajian yang sudah dilakukan Badan Litbang Kesehatan terkait jumlah pemohon paten untuk obat 4 penyakit (anti-malaria, anti-tuberkulosis, antidiabetes dan anti-hipertensi) dalam rentang waktu tahun 2005-2011 terlihat bahwa pemohon paten Indonesia mendaftarkan 3,4% dari 89 paten antihipertensi, 4,8% dari 250 paten anti diabetes, 21,1% dari 18 paten anti-malaria dan 7,1% dari 14 paten antituberkulosis, sedangkan sisanya didaftarkan oleh pemohon paten asing (Utami et al, 2014). Karena itu jelaslah bahwa pemohon paten di Indonesia masih didominasi oleh asing.…”

Section: Pendahuluanunclassified

“…Data dan informasi mengenai produk paten dan hak cipta yang ada saat ini masih menyatu dengan data produk paten/hak cipta lain yang ada di Direktorat Jenderal Kekayaan Intelektual Kemenhumham. Bila sistem informasi KI dikembangkan maka akan lebih mudah bagi setiap sektor untuk memperoleh akses data dan informasi produk yang telah dijadikan KI (Utami et al, 2014). Demikian pula, evaluasi mengenai perkembangan dan permasalahan terkait riset inovasi harus (Walsh, 2014), (Kaslow et al, 2017), (Grabowski, DiMasi and Long, 2015) Pada akhirnya, untuk lebih meningkatkan perkembangan HKI kesehatan di Indonesia agar dapat sejajar dengan negara-negara yang sudah maju, maka pemerintah perlu meningkatkan prioritas terhadap riset inovasi mulai dari perencanaan, pelaksanaan riset sampai manajemen pendukung seperti unit inkubasi dan yang tak kalah pentingnya adalah pemerintah harus berkomitmen untuk membantu memanfaatkan produk kesehatan yang telah memperoleh HKI (Simamora, 2011), (Santyaningtyas and Noor, 2016).…”

Section: Pembahasanunclassified

See 1 more Smart Citation

Analisis Situasi Hak Kekayaan Intelektual Bidang Kesehatan Di Indonesia

Siahaan¹,

Utami

Gitawati

et al. 2018

hsr

Self Cite

View full text Add to dashboard Cite

The information about intellectual property rights (IPR) related to health products in Indonesia is limited. This manuscript aims to describes the situation of health innovative researches including their products (patented and copyrights) in the last 5 years (2009-2013). This is a cross-sectional exploratory qualitative research, followed by the identifi cation of data and information related to health IPR documents retrospectively from 2009 till 2013. In-depth interviews conducted on IPR managers in 5 (fi ve) government research institutions, Indonesia Institute of Science, Agency for the Assessment and Application of Technology and 7 (seven) universities in Java island. The results showed that the IPR policy is strong, because it is written in the Act, majority of institutions state that IPR is their main indicators, however, the priority of health innovative researches is low. Generally, patented products were not planned to be patented from the beginning. Not all institutions have IPR management structured and incubation unit for development and “scaling up” of researches results, so that, patented health products were potentially not to be commercialised. This shows that there is still a gap between policy and its implementation in terms of research innovation. Governments should actively promote and utilize the patented health products of Indonesia. Abstrak Informasi tentang Hak Kekayaan Intelektual (HKI) di Indonesia yang terkait dengan produk kesehatan masih sangat kurang. Tulisan ini bertujuan memaparkan situasi penelitian inovatif dan produk hasil penelitian kesehatan terkait HKI (paten dan hak cipta) dalam 5 tahun terakhir (2009-2013). Studi ini merupakan penelitian kualitatif eksplorasi potong lintang disertai identifi kasi data dan informasi pada dokumen HKI bidang kesehatan secara retrospektif dari tahun 2009 sd 2013. Wawancara mendalam dilakukan terhadap pengelola HKI di 5 (lima) lembaga litbang kementerian, Lembaga Ilmiah Pengetahuan Indonesia, Badan Pengkajian dan Penerapan Teknologi dan 7 (tujuh) universitas di pulau Jawa. Hasil penelitian menunjukkan bahwa dasar kebijakan HKI Indonesia telah kuat karena sudah dituangkan kedalam Undangundang, hampir semua institusi yang disurvei menjadikan HKI sebagai indikator utama, hanya penelitian yang berorientasi HKI kesehatan masih kurang diprioritaskan. Pada umumnya hasil penelitian yang dipatenkan tidak direncanakan sejakawal. Belum semua institusi memiliki unit pengelola HKI secara terstruktur dan unit inkubasi untuk pengembangan dan scaling up hasil penelitian agar dimanfaatkan masyarakat luas sehingga produk paten kesehatan berpotensi menjadi yang tidak bisa dikomersialisasikan. Hal ini menunjukkan bahwa terdapat gap antara kebijakan dan implementasinya dalam hal penelitian inovasi. Pemerintah perlu secara aktif membantu mempromosikan dan memanfaatkan hasil produk kesehatan yang telah memperoleh HKI.

show abstract

Pelaksanaan Standarisasi Pemberian Paten Dalam Invensi Bidang Obat-Obatan Di Indonesia

Jaelani

Kurniawan

Indrastuti

2019

LJIH

View full text Add to dashboard Cite

This research is motivated by a patent given to Sanofi Pasteur, a French citizen who acts as a patent holder for Japanese encephalitis vaccine, measles, mumps, rubella using a pig enzyme in the form of trypsin as a catalyst in the process of making vaccines, whereas Article 9 letter a of Law Number 13 Year 2016 regarding Patents states that inventions that cannot be granted a Patent include processes or products that are announced, used or implemented in contravention of statutory regulations, religion, public order or decency. The purpose of this study is to analyze the standardization of the provision of patents in the field of medicine. This type of research is normative law. The data of this study are secondary data. Analysis of the data used is descriptive analytic. The research concludes that first, the background of the formation of the provisions of an invention that is considered to be contrary to religion in Indonesia as regulated in Article 9 letter a of the Law of the Republic of Indonesia Number 13 of 2016 is based on several justifications namely justification based on Article 27.2 and Article. 27.3 TRIPs Agreement and justification based on the translation of the Pancasila as the ideology of the Indonesian people, especially the Precepts of Godhead. Secondly, the provisions of an invention that is considered to be contrary to the religion of Islam in the field of medicines that contain illicit elements cannot be implemented because the provisions of Article 9 letter a of Law Number 13 Year 2016 are universal.

show abstract

Situasi Paten Obat Anti Diabetes, Anti Hipertensi, Anti Malaria Dan Anti Tuberkulosis Di Indonesia

Cited by 3 publications

References 0 publications

The significance of standard, patent and labour on import value: case study in Indonesia

The significance of standard, patent and labour on import value: case study in Indonesia

Analisis Situasi Hak Kekayaan Intelektual Bidang Kesehatan Di Indonesia

Pelaksanaan Standarisasi Pemberian Paten Dalam Invensi Bidang Obat-Obatan Di Indonesia

Contact Info

Product

Resources

About